TITLE

BIOCUREX/GOSHEN CANCER CENTER DEVELOPING RECAF

PUB. DATE
July 2005
SOURCE
Worldwide Biotech;Jul2005, Vol. 17 Issue 7, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Repots on the collaboration of BioCurex Inc. with the Center for Cancer Care in Goshen, Indiana for developing and evaluating its RECAF technology, as of July 2005. Details of the collaboration; Significance of the move in delivering therapeutic agents to destroy the cancer cells with minimal damage to normal tissues; Statement issued by Douglas Schwartzentruber, medical director of Goshen Health System's Center for Cancer Care, about the partnership.
ACCESSION #
17706735

 

Related Articles

  • Douglas Schwartzentruber and Larry Kwak. Shanteau, Eric // Time International (Atlantic Edition);5/10/2010, Vol. 175 Issue 18, p63 

    The article profiles medical researchers Douglas Schwartzentruber and Larry Kwak, both of whom are working to develop a cancer vaccine.

  • Douglas Schwartzentruber and Larry Kwak. Shanteau, Eric // Time;5/10/2010, Vol. 175 Issue 18, p107 

    The article profiles medical researchers Douglas Schwartzentruber and Larry Kwak, both of whom are working to develop a cancer vaccine.

  • Partnership improves paediatric services. Crellin, Dianne // Australian Nursing Journal;Jul2001, Vol. 9 Issue 1, p13 

    Focuses on the partnership between the Royal Children's Hospital and the Austin and Repatriation Medical Centre in Melbourne, Victoria. Improvements in pediatric services brought by the partnership; Benefit of the introduction of standardized clinical management guidelines in pediatric care.

  • Asan Medical Center and Harvard Medical International.  // Journal of Alternative & Complementary Medicine;Dec2001 Supplement 1, Vol. 7 Issue 6, p2 

    Focuses on the alliance of Asan Medical Center of Seoul, South Korea and Harvard Medical International of Harvard University School of Medicine. Background of the establishment of the medical institutions.

  • Community spotlight.  // AHA News;06/08/98, Vol. 34 Issue 22, p2 

    Focuses on a partnership between the Boston Medical Center and the Latino Health Institute in Boston, Massachusetts. Purpose of a project being undertaken by the two entities; Comments from Barry Zuckerman of Boston Medical Center, on language barriers in health care; Plan of the Latino Health...

  • OFF THE CLOCK.  // njbiz;6/6/2011, Vol. 24 Issue 23, p30 

    The article presents photographs of social events held by several New Jersey businesses, including the 2011 Transportation Awards breakfast of the Newark Regional Business Partnership, Jersey City Medical Center's formal announcement of its partnership with the Hoboken High School Emergency...

  • ZIOPHARM Announces Initial Positive Data Presented at 2011 ASCO Annual Meeting from First-Ever Treatment Demonstrating Small Molecule-Controlled Production of Anticancer Protein in Humans.  // Biomedical Market Newsletter;6/9/2011, p520 

    The article focuses on the announcment of Ziopharm Oncology Inc. on the initial positive clinical results of ZIN-CTI-001 phase Ib study presented by doctor Douglas J. Schwartzentruber on a session during the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting. It states that the...

  • ZIOPHARM Oncology to Present Data at 2011 ASCO Annual Meeting from First-Ever Treatment Demonstrating Small Molecule-Controlled Production of Anticancer Protein in Humans.  // Biomedical Market Newsletter;5/17/2011, p208 

    The article reports the presentation of Ziopharm Oncology Inc. at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held in Chicago, Illinois from June 3-7. It states that representative Douglas J. Schwartzentruber will discuss the results of the Phase Ib...

  • Blood: miR loss may power maligant transformation in chronic leukemia.  // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1 

    The article discusses a study by the researchers of the Ohio State University Medical Center which shows that miR-125b molecule is lost in chronic lymphocytic leukemia associated with a characteristic ofcancer cells including Warburg effect.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics